All 1 tracked stories fall under one category: acquisition. Biolife Solutions Inc. is most often covered alongside Repligen Corp., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Biolife Solutions Inc., all published on June 27, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Biolife Solutions Inc.
All 1 tracked stories fall under one category: acquisition. Biolife Solutions Inc. is most often covered alongside Repligen Corp., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Biolife Solutions Inc., all published on June 27, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Biolife Solutions Inc.. Shared-story counts are live from our verified record — not editorial picks.
Repligen’s reported interest in Biolife Solutions could create a bioprocessing-to-cryopreservation powerhouse. For the biotech industry, this deal promises an integrated supplier but raises concerns about supplier consolidation as the cell and gene therapy market expands at over 20% CAGR.